HAPLO-iPS aims to create a collaborative network to provide a framework for hiPSC generation of hiPSC homozygous for frequent HLA haplotypes, compatible with a significant percentage of the population to be used for cell therapy clinical trials and to create a data collection system (REGISTRY) for such lines.
HAPLO-iPS will establish an European-based excellence network on hiPSC-derived cell-based medicines that not only will boost the state-of-the-art of this research field if not will also contribute to Europe worldleadership through the medical, scientific, economic, and social development of Europe and strengthening
Europe’s competitiveness capacities. This network includes all the relevant stakeholders: hiPSC generation/banking centres, CB banks that will supply cord blood units; manufacturing centres (GMP complying), immunology experts, chemistry and manufacturing controls, regulatory bodies, National Agencies, and ethics experts. The challenge will be approached essentially by networking with all the stakeholders involved sharing knowledge, standardizing methodology and developing an educational training programme for researchers.
HAPLO-iPS is also promoting the participation of researchers from less research-intensive countries as a significant percentage of the members are from ITC countries. ITC participants will have access to research facilities, training courses, mentoring of ITC young researchers and will participate spreading excellence and widening participation programme. Furthermore, Key leadership positions in the Action Management are reserved to COST ITC.
Company Details
- Employees
- 1
- Address
- Av. Gran Via De L’hospitalet 199, L’hospitalet De Llobregat,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://haplo-ips.eu
- Keywords
- L'Hospitalet de Llobregat.
- HQ
- Barcelona
- Competitors
- P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia, Genalytics, TealSense, EMBL, (to delete, old), COST Association - European Cooperation in Science and Technology, Лаборатория Геника, Biobank Norway, Pluripotent Diagnostics (PDx) Corp., A BlockChain Factory.
Haplo-Ips Questions
Haplo-Ips's website is https://haplo-ips.eu
Haplo-Ips's LinkedIn profile is https://es.linkedin.com/company/haplo-ips
Haplo-Ips has
1 employees.
View email and phone details for 1
employees at Haplo-Ips.
Haplo-Ips's industry is
Biotechnology Research
Haplo-Ips's top competitors are
P-Cmr[C] Program For Clinical Translation Of Regenerative Medicine In Catalonia,
Genalytics,
Tealsense,
Embl,
(To Delete, Old),
Cost Association - European Cooperation In Science And Technology,
Лаборатория Геника,
Biobank Norway,
Pluripotent Diagnostics (Pdx) Corp.,
A Blockchain Factory.
Haplo-Ips's categories are Biotechnology Research
![P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia logo - Similar company to Haplo-Ips](https://cimg.aeroleads.com/ln/logos/e8/7e7b775df218583871a6da93c5c9d98e.jpg)
